Tadalafil for erectile dysfunction associated with cardiovascular diseases.
- Author:
Kai-Feng LIU
1
Author Information
1. Department of Urology, The Second Hospital Affiliated to Soochow University, Suzhou, Jiangsu 215004, China. 49993873@qq.com
- Publication Type:Journal Article
- MeSH:
Carbolines;
therapeutic use;
Cardiovascular Diseases;
complications;
drug therapy;
Erectile Dysfunction;
complications;
drug therapy;
Humans;
Male;
Phosphodiesterase Inhibitors;
therapeutic use;
Tadalafil
- From:
National Journal of Andrology
2013;19(9):860-863
- CountryChina
- Language:Chinese
-
Abstract:
Erectile dysfunction (ED) seriously affects the quality of men's sexual life. Recent studies have shown that ED is closely related with cardiovascular diseases, and they have many similar pathogenic mechanisms and common risk factors. A great many researches have confirmed the clinical efficacy of tadalafil in the treatment of ED associated with cardiovascular diseases. With its prolonged action of 36 hours, tadalafil can not only increase the self-confidence of ED males but also improve the quality of life of both the patients and their partners.
